PARATHYROID TUMOUR BENIGN

This adverse event was reported 742 times

These drugs are most commonly taken by patients reporting PARATHYROID TUMOUR BENIGN:

# Drug Count
0 CINACALCET 104
1 CINACALCET HYDROCHLORIDE 88
2 DENOSUMAB 54
3 ERGOCALCIFEROL 49
4 ALENDRONATE SODIUM 42
5 LITHIUM CARBONATE 42
6 ADALIMUMAB 39
7 LEVOTHYROXINE SODIUM 29
8 ASPIRIN 26
9 ASPIRIN 325 MG 26
See all common drugs associated with PARATHYROID TUMOUR BENIGN

PARATHYROID TUMOUR BENIGN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM IODIDE I 123 21 0.0223
1 SODIUM IODIDE I 131 21 0.0219
2 ALENDRONATE SODIUM AND CHOLECALCIFEROL 14 0.0051
3 ETELCALCETIDE 8 0.0028
4 LITHIUM CARBONATE 42 0.0025
5 FLUTAMIDE 2 0.0020
6 BARICITINIB 6 0.0020
7 PENICILLIN V POTASSIUM 5 0.0019
8 METHYLENE BLUE 3 0.0019
9 CINACALCET HYDROCHLORIDE 88 0.0019
See all drugs enriched for association with PARATHYROID TUMOUR BENIGN

PARATHYROID TUMOUR BENIGN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 49 0.0016
1 Vitamin D2 Analog [EPC] 11 0.0015
2 Calcitonin [EPC] 3 0.0010
3 Vitamin D3 Analog [EPC] 16 0.0008
4 Vitamin D Analog [EPC] 11 0.0006
5 Phosphate Binder [EPC] 1 0.0003
6 Monoamine Oxidase Inhibitor [EPC] 1 0.0003
7 RANK Ligand Inhibitor [EPC] 54 0.0003
8 Dopamine and Norepinephrine Reuptake Inhibitor [EPC] 1 0.0003
9 Blood Viscosity Reducer [EPC] 1 0.0002
See all drug classes enriched for association with PARATHYROID TUMOUR BENIGN